Riskpilot← Back to searchSign inGet full accessWehka-Medi Oy
OYDissolvedY-tunnus 2744617-6As. 11Medical specialists activities · NACE 8622Est. 2016— employees
Revenue 2025
EUR 198K
-9% vs 2024
EBITDA margin
61.8%
-23% vs 2024
Equity ratio
88.3%
Financial strength
Net profit 2025
EUR 97K
-23% vs 2024
| Revenue | EUR 198K | -9% |
| EBITDA | EUR 122K | -23% |
| Net profit | EUR 97K | -23% |
| Total assets | EUR 733K | +20% |
| Equity | EUR 647K | +6% |
| Employees | — | — |
Legal name
Wehka-Medi Oy
Y-tunnus number
2744617-6
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
10. helmikuuta 2016
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-11-30
Financial year
January – December
Company purpose
Lääkäripalvelujen tuottaminen potilaille, alan koulutus- ja konsultointipalvelujen tuottaminen, luennointi sekä kustannustoiminta. Yhtiö voi omistaa, hallita ja vuokrata kiinteistöjä, liike- ja asuinhuoneistoja sekä kulkuneuvoja. Yhtiö voi harjoittaa arvopaperikauppaa.
Address
As. 11
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 115 | 132 | 132 | 218 | 198 |
| Staff expenses | −6 | −7 | −7 | −11 | −22 |
| EBITDA | 57 | 78 | 78 | 159 | 122 |
| Depreciation & amort. | −1 | −1 | −1 | −1 | −1 |
| EBIT | 56 | 77 | 77 | 159 | 122 |
| Net financials | — | 0 | 0 | 0 | 0 |
| Profit before tax | 56 | 77 | 77 | 159 | 122 |
| Tax | 16 | 16 | 16 | 24 | 22 |
| Net profit | 41 | 62 | 62 | 126 | 97 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 445 | 471 | 580 | 611 | 733 |
| Equity | 443 | 470 | 558 | 611 | 647 |
| Long-term debt | — | — | 0 | 0 | 84 |
| Short-term debt | 2 | 2 | 22 | 10 | 2 |
| Total debt | 2 | 2 | 22 | 10 | 86 |
EBITDA margin
61.8%
This company
15.8%
Market median
+291% vs market
20212025
Equity ratio
88.3%
This company
38.2%
Market median
+131% vs market
20212025
Return on equity
15.0%
This company
18.4%
Market median
+18% vs market
20212025
Net profit margin
49.3%
This company
8.1%
Market median
+509% vs market
20212025
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20212025
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-12-01 – 2025-11-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-12-01 – 2021-11-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AK Chief Executive Officer | Chief Executive Officer | 2016 |
| Former (4) | ||
RA Deputy Member | Deputy Member | 2016 – 2023 |
JA | Audit | 2019 – 2022 |
NP | Audit | 2016 – 2019 |
PR Deputy auditor | Deputy auditor | 2019 – 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Wehka-Medi Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Karoliina Wehkalampi | Chief Executive Officer | 0 companies |
| Riitta Annuli Silvast | Deputy Member | 0 companies |
| Jose Adam Juhani Kautonen | Audit | 0 companies |
| Niina Pauliina Lettojärvi | Audit | 0 companies |
| Petteri Raine Lagus | Deputy auditor | 0 companies |